statistiche ricercatore

Continente	#
EU - Europa	863
NA - Nord America	827
AS - Asia	558
SA - Sud America	90
AF - Africa	11
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.355

Nazione	#
US - Stati Uniti d'America	806
RU - Federazione Russa	298
GB - Regno Unito	265
CN - Cina	215
SG - Singapore	195
BR - Brasile	72
SE - Svezia	65
IT - Italia	45
DE - Germania	39
FI - Finlandia	39
HK - Hong Kong	38
FR - Francia	37
VN - Vietnam	36
IE - Irlanda	29
KR - Corea	20
BE - Belgio	15
CA - Canada	14
TR - Turchia	13
UA - Ucraina	9
IN - India	8
ZA - Sudafrica	7
AR - Argentina	6
PL - Polonia	6
ID - Indonesia	5
JP - Giappone	5
MX - Messico	5
AU - Australia	4
BD - Bangladesh	4
CO - Colombia	3
CZ - Repubblica Ceca	3
IQ - Iraq	3
IR - Iran	3
JO - Giordania	3
LT - Lituania	3
NL - Olanda	3
A2 - ???statistics.table.value.countryCode.A2???	2
CL - Cile	2
EG - Egitto	2
ES - Italia	2
HU - Ungheria	2
PY - Paraguay	2
TN - Tunisia	2
UY - Uruguay	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BO - Bolivia	1
CR - Costa Rica	1
EC - Ecuador	1
IL - Israele	1
KH - Cambogia	1
KZ - Kazakistan	1
MY - Malesia	1
NO - Norvegia	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
SA - Arabia Saudita	1
Totale	2.355

Nome	#
Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis	239
Ascorbic Acid Induces either Differentiation or Apoptosis in MG-63 Osteosarcoma Lineage	237
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation	228
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells	222
Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.	184
Runx-2 gene expression is associated with age-related changes of bone mineral density in the healthy young-adult population	182
Histomorphometric analysis of glucocorticoid-induced osteoporosis	172
ANALISI DELL’ESPRESSIONE GENICA DI RUNX-2 E DELLADENSITA’ MINERALE OSSEA IN UNA POPOLAZIONEDI GIOVANI E ADULTI SANI	168
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?	159
Il profilo del clodronato nel trattamento dell’osteoporosi	158
Bone microarchitecture evaluated by histomorphometry	152
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.	136
Densitometric threshold and vertebral fractures in heart transplant patients	131
Totale	2.368

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	58	0	0	0	0	0	12	1	12	7	2	20	4
2021/2022	169	17	50	1	19	2	7	3	6	7	1	13	43
2022/2023	313	22	45	40	45	41	54	0	20	33	3	9	1
2023/2024	136	1	8	15	12	9	38	2	8	2	15	22	4
2024/2025	299	9	17	26	48	9	10	11	9	49	19	36	56
2025/2026	764	70	57	77	219	266	75	0	0	0	0	0	0
Totale													2.368

CATALOGO DEI PRODOTTI DELLA RICERCA